SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Infrastructure Regulatory News (PINT)

Share Price Information for Pantheon Infrastructure (PINT)

Share Price is delayed by 15 minutes
Get Live Data
115.60    -0.60 (-0.52%)
Bid:
115.00
Ask:
116.20
Spread: 1.20 (1.043%)
Market Cap: £541.73m
PINT Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Infrastructure Share Chart

Update research note from QuotedData

7 May 2026 15:14

RNS Number : 4809D
Pantheon Infrastructure PLC
07 May 2026
Β 

Β 

Pantheon Infrastructure - Update from QuotedData

7 May 2026

Moving to a new phase

Pantheon Infrastructure (PINT) delivered strong results in 2025, with an NAV total return above its 8-10% target. This was driven by solid operational performance, higher EBITDA and better cash generation. The full-year dividend was increased and fully covered. PINT is now moving from its initial buildout phase to a more mature stage, where cash generation, asset sales and reinvestment are key to returns.

This shift became clearer after year end. The sale of Calpine in January 2026, followed by a partial sale of Intersect, showed PINT's ability to both create and realise value. These deals highlight the strength of its approach: investing in assets with growth potential and recycling capital into new opportunities as the portfolio develops.

Full Research:

https://quoteddata.com/research/pantheon-infrastructure-moving-to-a-new-phase-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Pantheon Infrastructure Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRABSGDUDBGDGLR
Date   Source Headline
26th Sep 20247:00 amRNSInterim Report
23rd Sep 20246:04 pmRNSHolding(s) in Company
12th Sep 20246:00 pmRNSNotice of half-year results and analyst meeting
28th Aug 20245:34 pmRNSHolding(s) in Company
1st Jul 20247:00 amRNSPublication of Sustainability Report
24th Jun 20247:00 amRNSNet Asset Value(s)
21st Jun 202410:03 amRNSResult of AGM
23rd May 202410:06 amRNSHolding(s) in Company
1st May 20245:35 pmRNSTotal Voting Rights
25th Apr 20244:00 pmRNSNotice of AGM
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSAnnual Financial Report
21st Mar 20247:00 amRNSDividend Declaration
19th Mar 20244:46 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSRevolving Credit Facility
15th Mar 20247:00 amRNSNotice of Full Year Results And Analyst Meeting
7th Mar 20249:01 amRNSUpdate from QuotedData
1st Mar 20245:32 pmRNSTotal Voting Rights
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 202412:46 pmRNSTotal Voting Rights
23rd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20243:55 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20246:15 pmRNSHolding(s) in Company
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20243:42 pmRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSNet Asset Value(s)
14th Dec 20232:29 pmRNSHolding(s) in Company
1st Dec 202311:42 amRNSTotal Voting Rights
2nd Nov 20233:37 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:02 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
27th Oct 20234:00 pmRNSQuotedData's Weekly News & Interview
26th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
11th Oct 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:02 amRNSFirst Dividend Declaration – H1 2023
27th Sep 20237:00 amRNSInterim Report
25th Sep 20235:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.